Long-term implications of autologous HCT for caregiver quality of life: how does the survivor’s health matter?

This study examines caregiver quality of life (CQOL) 3–26 years after autologous hematopoietic cell transplantation (HCT) for patients with lymphoma. Using a framework that views the patient-caregiver dyad as a system of mutual influence, we argue that CQOL is associated with survivor functional health status and sense of personal control. Ninety-nine autologous HCT survivor-caregiver dyads participated. CQOL was measured using the Caregiver...